Kinsey Global Pty Ltd Chosen for Newchip’s Intensive Global Pre-Seed Accelerator Program

Kinsey Global Pty Ltd, a med-tech startup innovating sexual health products for women and LGBTQIA+ individuals, was accepted into Newchip’s renowned global accelerator program. Designed to provide all the skills and tools founders need to rapidly fund, build and scale their companies, past accelerator cohorts averaged more than 17.5 times the average funding amount. The equity-free, fully digital accelerator has helped over 1,500 founders from more than 50 countries and 250 cities raise over $450 million in funding with an estimated portfolio of over $9B.

“Newchip evaluates a diverse number of companies across all industries from around the world, selecting a small percentage to join our accelerator,” says Armando Vera Carvajal, Vice President of Product at Newchip. “This strict selection process makes us an ideal partner for investors looking for promising start-ups. Consumer-focused med-tech companies like Kinsey Global Pty Ltd can scale quickly with proper funding and guidance. We are excited for Kinsey Global and believe they will do well at Newchip.”

“Being accepted into the Newchip Accelerator, we are excited to learn how to build a scalable and investable business and connect with investors throughout the globe interested in our industry says Trang Nguyen, CEO.

About Kinsey Global

Kinsey Global is a consumer-facing med-tech company innovating sexual health products for women and LGBTQIA+ individuals. It was founded by sexologists, Trang Nguyen and Elizabeth Tekanyo in 2020.
Kinsey is on a mission to create the future of safe sex and democratise sexual health products globally. Since its inception, the company has created the DARCi; its flagship product – a prophylactic for sexually active couples who engage in oral-vaginal-sex that prevents STI/HIV transmissions. For more information on our journey or to participant in our survey, visit www.kinseyglobal.co.